Neurology

12.
Disorders of the Peripheral Nervous System
12.2.
Mononeuropathies
12.2.1.
Upper Extremity Mononeuropathies
12.2.1.1.
Median Nerve
12.2.1.1.1.
Carpal Tunnel Syndrome
12.2.1.1.1.1.
Anatomy
12.2.1.1.1.2.
Risk Factors
12.2.1.1.1.3.
Clinical Features
12.2.1.1.1.4.
Diagnosis
12.2.1.1.1.4.1.
Clinical Tests
12.2.1.1.1.5.
Management
12.2.1.1.1.5.1.
Conservative Treatment
12.2.1.1.1.5.2.
Surgical Treatment
12.2.1.2.
Ulnar Nerve
12.2.1.2.1.
Cubital Tunnel Syndrome
12.2.1.2.1.1.
Anatomy
12.2.1.2.1.2.
Risk Factors
12.2.1.2.1.3.
Clinical Features
12.2.1.2.1.4.
Diagnosis
12.2.1.2.1.5.
Management
12.2.2.
Lower Extremity Mononeuropathies
12.2.2.1.
Peroneal Nerve
12.2.2.1.1.
Common Peroneal Neuropathy
12.2.2.1.1.1.
Anatomy
12.2.2.1.1.2.
Risk Factors
12.2.2.1.1.3.
Clinical Features
12.2.2.1.1.4.
Diagnosis
12.2.2.1.1.5.
Management
12.2.2.3.
Femoral Nerve
12.2.2.3.3.
Diagnosis
12.2.2.3.4.
Management
12.2.2.5.
Sciatic Nerve
12.2.2.5.3.
Diagnosis
12.2.2.5.4.
Management
12.2.3.
Cranial Mononeuropathies
12.2.3.1.
Bell's Palsy
12.2.3.1.1.
Pathophysiology
12.2.3.1.3.
Diagnosis
12.2.3.1.4.
Management
12.2.3.1.4.1.
Corticosteroids
12.2.3.1.4.2.
Antiviral Therapy
12.2.3.1.4.3.
Supportive Care
12.2.3.1.5.
Prognosis
12.3.
Polyneuropathies
12.3.3.
Inflammatory Polyneuropathies
12.3.3.1.
Guillain-Barré Syndrome
12.3.3.1.2.
Pathophysiology
12.3.3.1.2.1.
Molecular Mimicry
12.3.3.1.2.2.
Autoimmune Response
12.3.3.1.3.
Clinical Features
12.3.3.1.3.2.
Sensory Symptoms
12.3.3.1.3.4.
Respiratory Failure
12.3.3.1.4.
Diagnosis
12.3.3.1.4.1.
Clinical Criteria
12.3.3.1.4.2.
CSF Analysis
12.3.3.1.4.4.
Antibody Testing
12.3.3.1.5.
Management
12.3.3.1.5.1.
Supportive Care
12.3.3.1.5.2.
Immunotherapy
12.3.3.1.5.2.1.
IVIG
12.3.3.1.5.2.2.
Plasma Exchange
12.3.3.1.5.3.
Monitoring
12.3.3.1.5.4.
Rehabilitation
12.3.3.1.6.
Prognosis
12.3.3.2.
Chronic Inflammatory Demyelinating Polyneuropathy
12.3.3.2.1.
Pathophysiology
12.3.3.2.3.
Diagnosis
12.3.3.2.3.1.
Clinical Criteria
12.3.3.2.3.3.
CSF Analysis
12.3.3.2.3.4.
Nerve Biopsy
12.3.3.2.4.
Management
12.3.3.2.4.1.
First-Line Therapy
12.3.3.2.4.1.1.
Corticosteroids
12.3.3.2.4.1.2.
IVIG
12.3.3.2.4.1.3.
Plasma Exchange
12.3.3.2.4.2.
Second-Line Therapy
12.3.3.2.4.3.
Maintenance Therapy
12.3.4.
Hereditary Neuropathies
12.3.4.1.
Charcot-Marie-Tooth Disease
12.3.4.1.1.
CMT1 (Demyelinating)
12.3.4.1.1.1.
CMT1A
12.3.4.1.1.2.
CMT1B
12.3.4.1.1.3.
CMT1X
12.3.4.1.2.
CMT2 (Axonal)
12.3.4.1.4.
Diagnosis
12.3.4.1.4.1.
Genetic Testing
12.3.4.1.4.3.
Family History
12.3.4.1.5.
Management
12.3.4.1.5.1.
Supportive Care
12.3.4.1.5.2.
Orthotic Devices
12.3.4.1.5.3.
Physical Therapy

Previous

11. Neuro-oncology

Go to top

Next

13. Neuromuscular Junction Disorders